15 Reasons to Invest in Walgreens!

  1. In 2013 Walgreen bought Alliance Boots, a chain of pharmacies in the UK that also sold health and beauty products in 11 countries. This drastically increased Walgreens product offering, supply chain, and market capitalization in the pharmaceutical industry.
  2. Walgreens Boots Alliance ranked 35 on the Fortune 1000 list.
  3. Walgreens has 13,100 stores in over 11 countries, which makes it the largest retail pharmacy in the U.S. and Europe.
  4. Revenue during Walgreen’s fiscal year in 2015 was 103,444 million. On the Fortune 500 list it was ranked #114 in revenue.
  5. The company has a S&P rating of BBB and Moody’s rating of Baa2.
  6. Walgreens received a perfect business credit rating of A+ from credit.net.
  7. Walgreens Boots Alliance was the 5th most admired food and drug store in 2015 according to Fortune magazine.
  8. Walgreens Boots Alliance has been ranked among Fortune’s “World’s Most Admired Companies” for the past 22 consecutive years.
  9. Walgreens Boots Alliance’s official website reports that it has over 8,100 Walgreens stores in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Approximately 76% of Americans live within 5 miles of a Walgreens store as of August 2015.
  10. Every day Walgreens interacts with about 8 million customers in its stores and online.
  11. Walgreens filled approximately 894 million prescriptions in fiscal 2015.
  12. American’s health care spending is expected to significantly increase in the next decade. In 2014, 17% of the nations gross domestic product was spent in the health care industry. An aging population and new health care initiatives are expected to help increase this proportion to 20% by 2020. Walgreens Boots Alliance projects this will bring 30 million more people into the health care system.
  13. Walgreens has increased the dividend given to shareholders for 40 consecutive years.
  14. According to a poll conducted by Civics Science, 49% of customers make all of their household purchases at Walgreens.
  15. In January 2016 Walgreens announced it plans to acquire RiteAid within the year. This will dramatically increase its market penetration and further strengthen its supply chain.

To learn more about our current DST tenants and properties, sign up now!


  1. OneSource Database
  2. Walgreens Newsroom – http://news.walgreens.com/fact-sheets/rankings-ratings.htm
  3. Insider Monkey – http://www.insidermonkey.com/blog/walgreens-boots-alliance-inc-wba-40-consecutive-years-of-dividend-growth-counting-460792/
  4. Civic Science – https://civicscience.com/researching-the-personas-of-cvs-rite-aid-and-walgreens-fans/
  5. Drug Store News – http://www.drugstorenews.com/article/walgreens-boots-alliance-names–initiatives-shareholders-meeting-will-fuel-growth?nocache=1
  6. Minyanville
  7. The Street – http://realmoney.thestreet.com/articles/04/11/2016/walgreens-rite-aid-deal-depends-selling-stores

About Kay Properties and www.kpi1031.com

Kay Properties is a national Delaware Statutory Trust (DST) investment firm. The www.kpi1031.com platform provides access to the marketplace of DSTs from over 25 different sponsor companies, custom DSTs only available to Kay clients, independent advice on DST sponsor companies, full due diligence and vetting on each DST (typically 20-40 DSTs) and a DST secondary market.  Kay Properties team members collectively have over 150 years of real estate experience, are licensed in all 50 states, and have participated in over $30 Billion of DST 1031 investments.

This material does not constitute an offer to sell nor a solicitation of an offer to buy any security. Such offers can be made only by the confidential Private Placement Memorandum (the “Memorandum”). Please read the entire Memorandum paying special attention to the risk section prior investing.  IRC Section 1031, IRC Section 1033 and IRC Section 721 are complex tax codes therefore you should consult your tax or legal professional for details regarding your situation.  There are material risks associated with investing in real estate securities including illiquidity, vacancies, general market conditions and competition, lack of operating history, interest rate risks, general risks of owning/operating commercial and multifamily properties, financing risks, potential adverse tax consequences, general economic risks, development risks and long hold periods. There is a risk of loss of the entire investment principal. Past performance is not a guarantee of future results. Potential cash flow, potential returns and potential appreciation are not guaranteed.

Nothing contained on this website constitutes tax, legal, insurance or investment advice, nor does it constitute a solicitation or an offer to buy or sell any security or other financial instrument. Securities offered through FNEX Capital, member FINRASIPC.

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedIn